E-ISSN: 2149-6447

Archives

Volume 7, Issue 1

March 2021

Back to Archives Download Issue

Editorial

Seyfettin Ilgan

Tamer Özülker

Review

How Use of Radioiodine Is Changing According to Risk Groups in Well Differentiated Thyroid Cancer?

Seyfettin Ilgan

Essentials of Thyroid Hormone Treatment in Differentiated Thyroid Cancer

Berna İmge Aydoğan

Alptekin Gürsoy

The Role of Thyroglobulin in the Management of Thyroid Cancers

Monitoring Effects of Anti-Tg Antibody Increase with Regards to Laboratory Implications and Solution Recommendations

Özlem Gülbahar

The Management of Anti-thyroglobulin Antibody Elevation in the Follow-up of Patients with Differentiated Thyroid Cancer

Should the Place of Radioactive Iodine Whole Body Scintigraphy in Follow-up of Differentiated Thyroid Cancer Reevaluated in the Era of SPECT/CT?

Nuriye Özlem Küçük

Non-ultrasonographic and Non-radioiodine Imaging Techniques in Thyroid Cancer

Options and Auxiliary Surgical Techniques in Residual or Recurrent Nodal Disease in Differentiated Thyroid Cancers

Mustafa Özdeş Emer

Early and Late Side Effects and Patient Management in I-131 Treatment

Use of Recombinant TSH in the Treatment and Monitoring of Well-Differentiated Thyroid Cancers

Differentiated Thyroid Carcinoma in Pediatric Age Group/Differences in Diagnosis, Therapy and Follow-up

Pınar Özgen Kıratlı